New Key Statistics Module, Z-Score and F-Score
TSX:EPRX Key Ratios
Market Cap C$ M | 142.49 |
Enterprise Value C$ M | 116.14 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 7.29 |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) C$ M | -- |
EPS (TTM) C$ | -0.93 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -14.60 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -4.89 |
EV-to-EBITDA | -4.92 |
PEG | -- |
Shares Outstanding M | 35.62 |
Net Margin (%) | -- |
Operating Margin % | -- |
Pre-tax Margin (%) | -- |
Quick Ratio | 1.95 |
Current Ratio | 1.95 |
ROA % (ttm) | -87.02 |
ROE % (ttm) | -210.02 |
ROIC % (ttm) | -238.20 |
Dividend Yield % | -- |
Altman Z-Score | -- |
TSX:EPRX Number of Guru Trades
TSX:EPRX Volume of Guru Trades
Gurus Latest Trades with TSX:EPRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
TSX:EPRX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Eupraxia Pharmaceuticals Inc Insider Transactions
No Available Data